Boston Scientific announced the U.S. launch of the DIRECTSENSE™ Technology for cardiac ablation catheters market
Growing catheter ablation procedures around the globe are primarily fueling growth of the cardiac ablation catheters market . According to the U.S. Department of Health & Human Services, it is estimated that 12.1 million people in the United States will have AFib in 2030. In 2018, AFib was mentioned on 175,326 death certificates and was the underlying cause of death in 25,845 of those deaths. Moreover, the rising aging population is again increasing prevalence of atrial fibrillation, atrial flutter and supraventricular tachycardia, and a decrease in heart muscle elasticity condition. This factor will also stimulate the growth of the market. According to the study by American Heart Association in 2017, catheter-based ablation procedures claim a 90% success rate with minimum risk of complications allowing patients to resume normal activities within a few days, thereby growing the demand for ablation catheters in surgical procedures. Rising prevalence of cardiac arrhythmia fue...